Publication | Closed Access

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

End-of-study ResultsBreast OncologyEarly-stage Breast CancerMedicineBreast CancerCancer TreatmentOncologyRadiation OncologyDose-dense Adjuvant Chemotherapy